Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 2/3 2Phase 1/2 2Phase NA 1Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 3Recurrence 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Motor Activity 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1Carcinoma, Hepatocellular 1

Interventions

Radiosurgery 24lenvatinib 19Radiofrequency Ablation 16Hepatectomy 13Sorafenib 12Surgical Procedures, Operative 9Radiotherapy 9camrelizumab 7Magnetic Resonance Spectroscopy 7Blood Specimen Collection 7Bevacizumab 7sintilimab 6apatinib 6Immune Checkpoint Inhibitors 6Electroporation 6atezolizumab 5tislelizumab 4Yttrium-90 4Proton Therapy 4Oxaliplatin 4Liver Transplantation 4Doxorubicin 4Control Groups 4Cisplatin 4Chemoembolization, Therapeutic 4Catheter Ablation 4spartalizumab 3entecavir 3X-Rays 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Hepatocellular × Thalidomide × Clear all
NCT01924624 2013-08-16

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

The First Affiliated Hospital of Xiamen University

Phase NA Unknown
140 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡